Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06685211 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Dec 31, 2026 → Jun 2027
See other at-risk trials from Stanford University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 31, 2026 to Jun 2027 Show 4 more changesShow less
    • Study completion pushed from Dec 31, 2027 to Jun 2028
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: details revised at 1 of 7 entries
    • Site contact updated
  2. Start date changed from estimate of Jul 1, 2025 to Jul 14, 2025
    • Eligibility criteria expanded, about 14 words
    • Site contact updated
    v4
  3. Phase: Phase 1/2 to Not applicable
    • Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    • Collaborator revised
    v3
  4. Start date: Mar 1, 2025 to Jul 1, 2025v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.
Trial Details
NCT Number NCT06685211
Lead Sponsor Stanford University
Collaborators: EYETRONIC, Inc
Conditions
(from sponsor)		 Glaucoma, Glaucoma Open-Angle
Related terms Glaucoma, Glaucoma, Open-Angle
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov